Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4880871 | 0.96 | TDP1 (0.42) | MAPK1TDP1HSD17B10 | |
| SCHEMBL21064941 | 0.87 | MAPK1 (0.41) | MAPK1TDP1 | |
| SCHEMBL17904930 | 0.87 | MAPK1 (0.41) | MAPK1TDP1 | |
| SCHEMBL27097628 | 0.84 | MAPK1 (0.48) | MAPK1TDP1 | |
| SCHEMBL27625763 | 0.81 | MAPK1 (0.48) | MAPK1TDP1MCHR1 | |
| SCHEMBL29083540 | 0.77 | TDP1 (0.46) | MAPK1TDP1HSD17B10 | |
| SCHEMBL2435517 | 0.77 | MAPK1 (0.45) | MAPK1 | |
| SCHEMBL24349580 | 0.77 | TDP1 (0.34) | TDP1 | |
| SCHEMBL27625764 | 0.76 | MAPK1 (0.48) | MAPK1TDP1MCHR1 | |
| SCHEMBL4888120 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1781245-B1 | METHOD FOR PERMANENT HAIR PROCESSING | SHOWA DENKO KK (JP) | 2012-11-14 | — | — | EP | disclosed |
| US-20080031839-A1 | Agent For Prermanent Hair Processing | SHOWA DENKO K.K. (JP) | 2008-02-07 | — | — | US | disclosed |
| CN-1976674-A | Agent for permanent hair processing | SHOWA DENKO KK (JP) | 2007-06-06 | — | — | CN | disclosed |
| EP-0962445-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS INC (JP) | 2003-02-26 | — | — | EP | disclosed |
| US-6217793-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS, INC. (JP) | 2001-04-17 | — | — | US | disclosed |
| EP-0962445-A1 | Acetylene compound, liquid crystal composition and liquid crystal element | Mitsui Chemicals, Inc. (JP) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080031839-A1 | Agent For Prermanent Hair Processing | POLR1C, LMNA, H1-0 | MAPK1 295/4885TDP1 2883/4885HSD17B10 359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.